Leveraging microbiome-based interventions to improve the management of neurodegenerative diseases: evidence for effects along the microbiota-gut-brain axis.
- 2025-12-11
- Review
- Frontiers in nutrition 12
- Noémie Auclair-Ouellet
- Ola Kassem
- Stéphane Bronner
- Marie-Laure Oula
- Sylvie Binda
- PubMed: 41459056
- DOI: 10.3389/fnut.2025.1699884
- Low evidence
Evidence related to biomarkers of pathology (e.g., beta-amyloid or alpha-synuclein protein depositions), neuroinflammation, and metabolic activity is summarized, along with emerging evidence for the improvement of clinical symptoms and disease trajectories.
- Effect
- Beneficial
- Effect size
- Small